Vanda Pharmaceuticals
VNDA
VNDA
137 hedge funds and large institutions have $711M invested in Vanda Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 133 → 137 (+4)
1.33% more ownership
Funds ownership: 87.22% → 88.55% (+1.3%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
137
Holding in Top 10
2
Calls
$6.47M
Puts
$1.16M
Top Buyers
| 1 | +$23.5M | |
| 2 | +$18M | |
| 3 | +$7.59M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$7.01M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$6.31M |
Top Sellers
| 1 | -$33M | |
| 2 | -$31.1M | |
| 3 | -$9.52M | |
| 4 |
NC
Nexthera Capital
New York
|
-$7.53M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$6.89M |